Auna (AUNA) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru and Mexico, focusing on high-complexity diseases and value-based care.
Aims to expand access to affordable, high-quality healthcare across Spanish-speaking Latin America through integrated digital and physical channels.
Segments include Oncosalud Peru (prepaid plans and oncology), Healthcare Services in Peru, Colombia, and Mexico.
Redomiciled from Peru to Luxembourg in July 2023 via merger.
Financial performance and metrics
As of December 31, 2024: cash and cash equivalents of $62.6M, total loans and borrowings of $792.1M (secured) and $208.9M (unsecured), total equity of $1,432.2M.
Share capital: $321.1M; share premium: $1,208.6M; reserves: $139.4M; retained losses: $(72.7)M.
Use of proceeds and capital allocation
Net proceeds from primary offerings will be used for general corporate purposes, with management retaining broad discretion over allocation.
No proceeds will be received from the sale of shares by selling securityholders.
Latest events from Auna
- Revenue up 13% YoY, strong cash flow, margin down, guidance reaffirmed.AUNA
Q1 2026 - FY25 saw strong cash flow, Peru and Colombia growth, and a 12% FXN growth target for 2026.AUNA
Q4 2025 - Healthcare group targets $1B NYSE offering to expand Latin American operations.AUNA
Registration Filing - Peru and Colombia drove growth, Mexico lagged; leverage stable, refinancing and recovery plans set.AUNA
Q3 2025 - Adjusted EBITDA up 5% FXN YoY; net income surged; leverage steady amid FX headwinds.AUNA
Q2 2025 - Adjusted EBITDA up 23% YoY, leverage ratio at 3.7x, and OncoMexico pilot advancing.AUNA
Q3 2024 - Adjusted EBITDA up 31% YoY, revenue up 18% YoY, and leverage ratio improved to 4.13x.AUNA
Q2 2024 - Peru's growth offset Mexico and Colombia's declines, sustaining profitability and stable leverage.AUNA
Q1 2025 - FY24 Adjusted EBITDA up 20.1% FXN, margin and net income improved, leverage at 3.6x.AUNA
Q4 2024